Avalon Ventures Xi, L.P. Janux Therapeutics, Inc. (JANX) insider trading activity
Avalon Ventures Xi, L.P. is of Janux Therapeutics, Inc.. Currently has a direct ownership of 2.07 Million shares of JANX, which is worth approximately $113 Million. The most recent transaction as insider was on Oct 18, 2024, when has been sold 660,018 shares (Common Stock) at a price of $48.74 per share, resulting in proceeds of $32,169,277. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
2.07M
36.67%
3M change
52.78%
12M change
Total Value Held
$113 Million
Avalon Ventures XI, L.P. Transaction History
AVX
Avalon Ventures Xi, L.P.
La Jolla, CA